Protagonist Therapeutics (PTGX)

8.61 +0.21 (2.50%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (6/4/18 *Est.)

Latest Headlines

Protagonist Therapeutics Reports Granting of Inducement Award September 19, 2018 7:00 AM - PR NewsWire Form S-3 Protagonist Therapeutics September 7, 2018 6:05 AM - SEC Filing Protagonist Therapeutics (PTGX) Announces $1.45M SBIR Funding for Development of PTG-300 September 6, 2018 7:24 AM - StreetInsider Protagonist Therapeutics Receives $1.45 Million SBIR Funding for the Development of PTG-300 September 6, 2018 7:01 AM - PR NewsWire Protagonist Therapeutics Expands Intellectual Property Portfolio September 6, 2018 7:00 AM - PR NewsWire Form SC 13G Protagonist Therapeutics Filed by: FARALLON CAPITAL MANAGEMENT LLC August 20, 2018 6:03 AM - SEC Filing Form 4 Protagonist Therapeutics For: Aug 15 Filed by: O'Neil Thomas P. August 17, 2018 8:31 PM - SEC Filing Form 4 Protagonist Therapeutics For: Aug 15 Filed by: Shames Richard S. August 17, 2018 8:28 PM - SEC Filing Form 4 Protagonist Therapeutics For: Aug 15 Filed by: PATEL DINESH V PH D August 17, 2018 8:27 PM - SEC Filing Form 4 Protagonist Therapeutics For: Aug 15 Filed by: Liu David Y August 17, 2018 8:25 PM - SEC Filing Protagonist Therapeutics Reports Granting of Inducement Award August 17, 2018 4:30 PM - PR NewsWire Form SC 13G/A Protagonist Therapeutics Filed by: BIOTECHNOLOGY VALUE FUND L P August 10, 2018 4:41 PM - SEC Filing Form 10-Q Protagonist Therapeutics For: Jun 30 August 7, 2018 5:32 PM - SEC Filing Form 8-K Protagonist Therapeutics For: Aug 07 August 7, 2018 4:51 PM - SEC Filing Protagonist Therapeutics Reports Second Quarter 2018 Financial Results August 7, 2018 4:01 PM - PR NewsWire Protagonist Therapeutics (PTGX) Enters Securities Purchase Agreement for Up 2.75M Shares August 7, 2018 6:44 AM - StreetInsider Form 424B5 Protagonist Therapeutics August 7, 2018 6:10 AM - SEC Filing Form 8-K Protagonist Therapeutics For: Aug 06 August 7, 2018 6:06 AM - SEC Filing Protagonist Therapeutics (PTGX) PT Raised to $18 at BTIG August 7, 2018 5:01 AM - StreetInsider Protagonist Therapeutics (PTGX) PT Raised to $21 at Leerink Partners August 6, 2018 1:05 PM - StreetInsider Form 8-K Protagonist Therapeutics For: Aug 06 August 6, 2018 7:24 AM - SEC Filing Protagonist Therapeutics (PTGX) Secures $22 Million Equity Financing August 6, 2018 7:08 AM - StreetInsider Protagonist Therapeutics (PTGX) Says Final Results from Protagonist PROPEL Study Support Further Clinical Development of PTG-100 August 6, 2018 7:08 AM - StreetInsider Final Results from the Protagonist PROPEL Study Support Further Clinical Development of PTG-100 for the Treatment of Ulcerative Colitis August 6, 2018 7:01 AM - PR NewsWire Protagonist Therapeutics Secures $22 Million Equity Financing August 6, 2018 7:00 AM - PR NewsWire Form 4 Protagonist Therapeutics For: Jul 12 Filed by: PATEL DINESH V PH D July 13, 2018 6:37 PM - SEC Filing Form SC 13G Protagonist Therapeutics Filed by: GREAT POINT PARTNERS LLC July 2, 2018 4:05 PM - SEC Filing Full Article List